Atrial fibrillation and flutter in patients hospitalized for COVID-19: The challenging role of digoxin

J Cardiovasc Electrophysiol. 2021 Mar;32(3):878-879. doi: 10.1111/jce.14894. Epub 2021 Feb 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation* / diagnosis
  • Atrial Fibrillation* / drug therapy
  • Atrial Flutter* / diagnosis
  • Atrial Flutter* / drug therapy
  • COVID-19*
  • Digoxin / adverse effects
  • Humans
  • SARS-CoV-2

Substances

  • Digoxin